Name
warf1
Label
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1)
Description

Participant taking ORAL ANTICOAGULANTS INCLUDING WARFARIN, COUMADIN, AND ANISINDIONE within two weeks of the SHHS1 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No 5,653 - -
Yes 133 - -
Unknown 18 4,080 5,042
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No 1,434 1,439 1,408 1,372 5,653
Yes 7 9 43 74 133
Unknown 10 3 - 5 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No 2,984 2,669 5,653
Yes 48 85 133
Unknown 7 11 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No - - -
Yes - - -
Unknown 2,219 1,861 4,080
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No 4,776 503 10 85 276 3 5,653
Yes 121 7 1 2 2 - 133
Unknown 10 5 - 1 2 - 18
Oral anticoagulants including warfarin, coumadin, and anisindione (SHHS1) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No - - - - - - -
Yes - - - - - - -
Unknown 3,587 256 8 48 180 1 4,080